Eventide Asset Management »

Krystal Biotech shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 137k 124.06

More positions owned by Eventide Asset Management

Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Zentalis Pharmaceuticals (ZNTL)
Old Dominion Freight Line (ODFL)
Celldex Therapeutics Com New (CLDX)
Roper Industries (ROP)
Crowdstrike Hldgs Cl A (CRWD)
IDEXX Laboratories (IDXX)
Palo Alto Networks (PANW)
Waste Connections (WCN)
D.R. Horton (DHI)
Pool Corporation (POOL)
Guardant Health (GH)
Global E Online SHS (GLBE)
Flywire Corporation Com Vtg (FLYW)

View all positions for Eventide Asset Management

Top funds holding Krystal Biotech

venBio Select Advisor
Vanguard Group
Redmile Group
Frazier Life Sciences Management
Jennison Associates
Lord, Abbett & Co
Dimensional Fund Advisors
Ikarian Capital
Credit Suisse
T. Rowe Price Associates
Balyasny Asset Management
TimesSquare Capital Management
First Turn Management
Goldman Sachs Group
Jpmorgan Chase & Co

View all funds holding Krystal Biotech